Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis

We investigated the kinetics of CRP, PCT, IL-6 and MR-proADM in a cohort of consecutive febrile patients with cancer in order to test the hypothesis that higher plasma concentrations and the absence of a rapid decrease in peak values would be associated with disease severity. (1) Method: A prospecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana de Lucio Delgado, Jose Antonio Villegas Rubio, Corsino Rey Galan, Belen Prieto García, Maria de los Reyes González Expósito, Gonzalo Solís Sánchez
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/5935da066f0440cea8a868e405d7a0b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5935da066f0440cea8a868e405d7a0b3
record_format dspace
spelling oai:doaj.org-article:5935da066f0440cea8a868e405d7a0b32021-11-25T17:14:39ZBiomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis10.3390/children81110272227-9067https://doaj.org/article/5935da066f0440cea8a868e405d7a0b32021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9067/8/11/1027https://doaj.org/toc/2227-9067We investigated the kinetics of CRP, PCT, IL-6 and MR-proADM in a cohort of consecutive febrile patients with cancer in order to test the hypothesis that higher plasma concentrations and the absence of a rapid decrease in peak values would be associated with disease severity. (1) Method: A prospective descriptive and analytical study of patients with cancer and fever (≤18 years of age) at a University Hospital was carried out between January 2018 and December 2019. Information collected: sex, age, diagnosis, date and symptoms at diagnosis and medical history. The episodes were classified into three groups: bacterial infection, non-bacterial infection and systemic inflammatory response syndrome (SIRS). (2) Results: One hundred and thirty-four episodes were included. Bacterial infection criteria were met in 38 episodes. Biomarkers were measured at four different points: baseline, at 12–24 h, at 25–48 h and at 49–72 h. All the biomarkers evaluated decreased after the peak level was reached. IL-6 and MR-proADM showed a trend towards higher levels in the SIRS group although this rise was statistically significant only for IL-6 (<i>p</i> < 0.005). Bacterial infections more frequently presented values of PCT above the cut-off point (>0.5 ng/mL) at 12–24 h. (3) Conclusion: In our experience, IL-6 kinetics is faster than PCT kinetics and both are faster than CRP in patients with fever and cancer who present a good outcome. Patients with a good evolution show a rapid increase and decrease of PCT and particularly of IL-6 levels.Ana de Lucio DelgadoJose Antonio Villegas RubioCorsino Rey GalanBelen Prieto GarcíaMaria de los Reyes González ExpósitoGonzalo Solís SánchezMDPI AGarticlecancerchildrenfeverPediatricsRJ1-570ENChildren, Vol 8, Iss 1027, p 1027 (2021)
institution DOAJ
collection DOAJ
language EN
topic cancer
children
fever
Pediatrics
RJ1-570
spellingShingle cancer
children
fever
Pediatrics
RJ1-570
Ana de Lucio Delgado
Jose Antonio Villegas Rubio
Corsino Rey Galan
Belen Prieto García
Maria de los Reyes González Expósito
Gonzalo Solís Sánchez
Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
description We investigated the kinetics of CRP, PCT, IL-6 and MR-proADM in a cohort of consecutive febrile patients with cancer in order to test the hypothesis that higher plasma concentrations and the absence of a rapid decrease in peak values would be associated with disease severity. (1) Method: A prospective descriptive and analytical study of patients with cancer and fever (≤18 years of age) at a University Hospital was carried out between January 2018 and December 2019. Information collected: sex, age, diagnosis, date and symptoms at diagnosis and medical history. The episodes were classified into three groups: bacterial infection, non-bacterial infection and systemic inflammatory response syndrome (SIRS). (2) Results: One hundred and thirty-four episodes were included. Bacterial infection criteria were met in 38 episodes. Biomarkers were measured at four different points: baseline, at 12–24 h, at 25–48 h and at 49–72 h. All the biomarkers evaluated decreased after the peak level was reached. IL-6 and MR-proADM showed a trend towards higher levels in the SIRS group although this rise was statistically significant only for IL-6 (<i>p</i> < 0.005). Bacterial infections more frequently presented values of PCT above the cut-off point (>0.5 ng/mL) at 12–24 h. (3) Conclusion: In our experience, IL-6 kinetics is faster than PCT kinetics and both are faster than CRP in patients with fever and cancer who present a good outcome. Patients with a good evolution show a rapid increase and decrease of PCT and particularly of IL-6 levels.
format article
author Ana de Lucio Delgado
Jose Antonio Villegas Rubio
Corsino Rey Galan
Belen Prieto García
Maria de los Reyes González Expósito
Gonzalo Solís Sánchez
author_facet Ana de Lucio Delgado
Jose Antonio Villegas Rubio
Corsino Rey Galan
Belen Prieto García
Maria de los Reyes González Expósito
Gonzalo Solís Sánchez
author_sort Ana de Lucio Delgado
title Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
title_short Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
title_full Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
title_fullStr Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
title_full_unstemmed Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
title_sort biomarkers and fever in children with cancer: kinetics and levels according to final diagnosis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/5935da066f0440cea8a868e405d7a0b3
work_keys_str_mv AT anadeluciodelgado biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
AT joseantoniovillegasrubio biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
AT corsinoreygalan biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
AT belenprietogarcia biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
AT mariadelosreyesgonzalezexposito biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
AT gonzalosolissanchez biomarkersandfeverinchildrenwithcancerkineticsandlevelsaccordingtofinaldiagnosis
_version_ 1718412588294864896